Streetbeat News

Analyst Ratings

BMY

Morgan Stanley analyst Terence Flynn has reiterated an 'Underweight' rating on Bristol-Myers Squibb (BMY) and maintained a price target of $59.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:04 pm

BLUE

Morgan Stanley analyst Matthew Harrison has reiterated an 'Underweight' rating on bluebird bio (NASDAQ:BLUE) and maintained a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:03 pm

PEP

PepsiCo, Inc. (NASDAQ:PEP) is expected to report higher Q2 2023 earnings of $1.95 per share, up from $1.86 per share a year ago. The company's revenue is projected to be $19.79 billion. PepsiCo shares rose 0.7% to close at $184.30 on Monday. Several analysts have recently adjusted their price targets for the company, with the most optimistic target set at $210 by Morgan Stanley.

Portfolio Pulse from Lisa Levin

July 11, 2023 | 1:02 pm

XPO

Vertical Research analyst Jeffrey Kauffman has downgraded XPO Logistics (NYSE:XPO) from Buy to Hold.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 1:02 pm

PCOR

Over the past 3 months, 11 analysts have published their opinion on Procore Technologies (NYSE:PCOR) stock. The average price target for Procore Technologies has increased by 5.53% from the previous average price target of $74.00 to $78.09. The majority of the analysts are bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:02 pm

BNTX

Morgan Stanley analyst Matthew Korn has maintained an Equal-Weight rating on BioNTech (NASDAQ:BNTX) but lowered the price target from $124 to $119.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:02 pm

ACAD

Analysts have provided various ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD) within the last quarter, with 2 bullish, 4 somewhat bullish, and 5 indifferent. The average price target is $25.33, implying an upside from the current price of $24.77. This average price target has increased by 16.19% over the past month.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:02 pm

CSX

Over the past three months, 13 analysts have published their opinions on CSX Corporation's stock. The majority of these analysts are somewhat bullish, with an average price target of $34.69, which is higher than the current price of $33.61. This average has increased by 5.12% from the previous average price target of $33.00.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:02 pm

RBLX

Roblox's (NYSE:RBLX) short percent of float has risen 4.37% since its last report, with 19.46 million shares sold short, which is 5.01% of all regular shares available for trading. It would take traders 2.53 days to cover their short positions on average. The increase in short interest can signal that investors have become more bearish. Roblox's peer group average for short interest as a percentage of float is 3.46%, indicating the company has more short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:01 pm

ZTS

Zoetis's (NYSE:ZTS) short percent of float has fallen 11.54% since its last report, with 3.19 million shares sold short, which is 0.69% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards Zoetis. Compared to its peers, Zoetis has less short interest as a percentage of float, with an average of 3.54%.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:01 pm